Inventor
PARREN PAUL
NL131 patents
⚠️ This page may combine multiple inventors who share the name “PARREN PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB AS
17 patentsUS7829673B2Nov 9, 2010
Antibodies against CD38 for treatment of multiple myeloma
GENMAB AS148 citations97
US7438907B2Oct 21, 2008
Human monoclonal antibodies against CD25
GENMAB AS50 citations95
US7282568B2Oct 16, 2007
Human monoclonal antibodies against interleukin 8 (IL-8)
GENMAB AS39 citations95
US11440966B2Sep 13, 2022
Multispecific antibodies against CD40 and CD137
GENMAB AS12 citations94
US10597464B2Mar 24, 2020
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS35 citations93
US10590206B2Mar 17, 2020
Inert format
GENMAB AS29 citations93
US10544220B2Jan 28, 2020
Bispecific antibodies against CD3 and CD20
GENMAB AS18 citations93
US10407501B2Sep 10, 2019
Humanized or chimeric CD3 antibodies
GENMAB AS15 citations93
US10344050B2Jul 9, 2019
Production of heterodimeric proteins
GENMAB AS40 citations91
US9944711B2Apr 17, 2018
Antibodies against human CD38
GENMAB AS16 citations91
US7850962B2Dec 14, 2010
Human monoclonal antibodies against CD20
GENMAB AS27 citations91
US11866514B2Jan 9, 2024
Heterodimeric antibody Fc-containing proteins and methods for production thereof
GENMAB AS5 citations85
US11485796B2Nov 1, 2022
Inert format
GENMAB AS6 citations85
US11091557B2Aug 17, 2021
Methods of producing multispecific antibodies against CD40 and CD137
GENMAB AS10 citations85
US11084882B2Aug 10, 2021
Multispecific antibodies against CD40 and CD137
GENMAB AS8 citations84
US10906991B2Feb 2, 2021
Bispecific antibodies and methods for production thereof
GENMAB AS15 citations84
US9657107B2May 23, 2017
Monoclonal antibodies against c-Met
GENMAB AS9 citations84
H LUNDBECK AS
11 patentsUS10800836B2Oct 13, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS10 citations92
US10647763B2May 12, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS9 citations92
US10647764B2May 12, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS9 citations92
US10640554B2May 5, 2020
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS9 citations92
US10364285B2Jul 30, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS13 citations92
US10358482B2Jul 23, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS11 citations92
US10358484B2Jul 23, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS13 citations92
US10358483B2Jul 23, 2019
Antibodies for the treatment of synucleinopathy
H LUNDBECK AS13 citations92
US11542323B2Jan 3, 2023
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US11524995B2Dec 13, 2022
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US11421024B2Aug 23, 2022
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
HOFFMANN LA ROCHE
3 patentsUS7563441B2Jul 21, 2009
Anti-P-selectin antibodies
HOFFMANN LA ROCHE94 citations98
US7824684B2Nov 2, 2010
Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
HOFFMANN LA ROCHE14 citations92
US7572897B2Aug 11, 2009
Antibodies against insulin-like growth factor I receptor and uses thereof
HOFFMANN LA ROCHE19 citations92
ROCHE PALO ALTO LLC
3 patentsLABRIJN ARAN FRANK
2 patentsJANSSEN BIOTECH INC
2 patentsDE GOEIJ BART
2 patentsSCHUURMAN JANINE
1 patentTEELING JESSICA
1 patentGENMAB
1 patentVAN DE WINKEL JAN
1 patentDE WEERS MICHEL
1 patentSATIJN DAVID
1 patentENDL JOSEPH
1 patentVERPLOEGEN SANDRA
1 patentGENMAB BV
1 patentPARREN PAUL
1 patentShowing the top 50 of 131 patents by PatentIndex Score.